StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3046% below fair value
$24.66−0.19 (-0.76%)

Close on Nov 13, 2026Market cap $678.53MP/E –Yield –

Fulgent Genetics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Fulgent Genetics's enterprise value was $445.95M on Nov 11, 2026, against $791.85M a year earlier. Over the last 5 years it ranged from $132.73M to $2.80B, with a median of $657.62M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$445.95M-35.3%
2025Dec 31, 2025$689.72M+36.6%
2024Dec 31, 2024$504.92M-35.9%
2023Dec 29, 2023$787.37M+9.4%
2022Dec 30, 2022$719.48M-74.3%
2021Dec 31, 2021$2.80B+145.7%
2020Dec 31, 2020$1.14B+445.8%
2019Dec 31, 2019$208.76M+747.3%
2018Dec 31, 2018$24.64M-64.0%
2017Dec 29, 2017$68.36M-51.3%
2016Dec 30, 2016$140.42M–

More Fulgent Genetics figures

See a number that looks wrong?